Preparation and crystallographic analysis of gliclazide polymorphs.

about

Preparation and crystallographic analysis of gliclazide polymorphs.

Item

http://www.wikidata.org/entity/Q43182734

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Preparation and crystallographic analysis of gliclazide polymorphs.

@en

Preparation and crystallographic analysis of gliclazide polymorphs.

@nl

type

Item

label

Preparation and crystallographic analysis of gliclazide polymorphs.

@en

Preparation and crystallographic analysis of gliclazide polymorphs.

@nl

prefLabel

Preparation and crystallographic analysis of gliclazide polymorphs.

@en

Preparation and crystallographic analysis of gliclazide polymorphs.

@nl

P1476

Preparation and crystallographic analysis of gliclazide polymorphs

@en

P2093

A J Rajamma

http://www.w3.org/2001/XMLSchema#string

A M Karthik

http://www.w3.org/2001/XMLSchema#string

M K Narode

http://www.w3.org/2001/XMLSchema#string

S B Sateesha

http://www.w3.org/2001/XMLSchema#string

V R S S Prashanth

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacologic therapy for type 2 diabetes mellitus.

Macromolecular crystal annealing: evaluation of techniques and variables.

Crystal structures of drugs: advances in determination, prediction and engineering.

Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Current perspectives of solubilization: potential for improved bioavailability.

Type 2 diabetes and oral antihyperglycemic drugs.

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Dissolution enhancement of gliclazide using pH change approach in presence of twelve stabilizers with various physico-chemical properties.

Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.

Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide.

P304

34-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0250-474X.151595

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25767316

http://www.w3.org/2001/XMLSchema#string

P932

4355880

http://www.w3.org/2001/XMLSchema#string